RxDoctor Payments Data

Pasquale Cancelliere, DPM

Podiatrist · Somerville, MANPI 1184860835

Payments from drug & device makers

What this record shows

This record is dominated by other: $315,510 of the $374,311 with a category attached, or 84.3%. Convatec Inc. accounts for 84.3% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $327,224 and has fallen 98.1% since, to $6,349 in 2025. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$374,311in general payments, 2019–2025

Across 282 payments — averaging $1327.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$316K
  • Amgen$48K
  • DNE LLC$5K
  • Triad Life Sciences Inc.$2K
  • Paratek Pharmaceuticals, Inc.$589
  • Linvatec Corporation$525
  • plus $3K from 22 others

What the payments were for

  • Speaking & faculty fees$45,82312%
  • Travel & lodging$6,2452%
  • Food & beverage$6,7192%
  • Entertainment$140%
  • Other$315,51084%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$374,311 in reported general payments places this provider in the 95th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$1,956,039
Medicare patients
308
Services billed
2,651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole73$3,618
Naftifine Hcl14$2,375
Nystatin45$1,119
Gentamicin Sulfate16$577
Celecoxib53$478
Ibandronate Sodium12$286
Doxycycline Hyclate18$163
NystopNystatin13$147
Clindamycin Hcl49$144
Tramadol Hcl54$128
Ondansetron Hcl29$111
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$69
Lorazepam38$20

Paid to pharmacies, not to this prescriber.

Other podiatrist in Somerville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →